Latest filings (excl ownership)
15-12B
Securities registration termination
27 Feb 17
CT ORDER
Confidential treatment order
27 Feb 17
25-NSE
Exchange delisting
16 Feb 17
8-K
Entry into a Material Definitive Agreement
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Feb 17
SC 14D9/A
Tender offer solicitation (amended)
16 Feb 17
SC TO-T/A
Third party tender offer statement (amended)
16 Feb 17
SC TO-T/A
Third party tender offer statement (amended)
8 Feb 17
SC 14D9/A
Tender offer solicitation (amended)
7 Feb 17
8-K
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency
6 Feb 17
SC TO-T/A
Third party tender offer statement (amended)
2 Feb 17
SC 14D9/A
Tender offer solicitation (amended)
30 Jan 17
SC TO-T/A
Third party tender offer statement (amended)
30 Jan 17
SC 14D9/A
Tender offer solicitation (amended)
24 Jan 17
SC 14D9/A
Tender offer solicitation (amended)
24 Jan 17
SC TO-T/A
Third party tender offer statement (amended)
24 Jan 17
SC 14D9
Tender offer solicitation
19 Jan 17
SC TO-T
Third party tender offer statement
19 Jan 17
SC TO-C
Information about tender offer
11 Jan 17
8-K
Entry into a Material Definitive Agreement
10 Jan 17
SC TO-C
Information about tender offer
10 Jan 17
SC TO-C
Information about tender offer
9 Jan 17
SC14D9C
Written communication relating to third party tender offer
9 Jan 17
UPLOAD
Letter from SEC
22 Dec 16
8-K
Other Events
8 Dec 16
8-K
Departure of Directors or Certain Officers
7 Dec 16
CORRESP
Correspondence with SEC
7 Dec 16
8-K
Other Events
30 Nov 16
UPLOAD
Letter from SEC
23 Nov 16
8-K
ARIAD Announces Data Presentations at the World Conference on Lung Cancer
18 Nov 16
10-Q
2016 Q3
Quarterly report
8 Nov 16
Latest ownership filings
4
Theseus Pharmaceuticals, Inc.
15 Oct 21
3
Theseus Pharmaceuticals, Inc.
15 Oct 21
SC 13G/A
Ariad Pharmaceuticals Inc
7 Apr 17
SC 13D/A
Ariad Pharmaceuticals Inc
21 Feb 17
4
George Bickerstaff
16 Feb 17
4
Paris Panayiotopoulos
16 Feb 17
4
Jennifer Lyn Herron
16 Feb 17
4
Manmeet Singh Soni
16 Feb 17
4
Jayne M. Gansler
16 Feb 17
4
TIMOTHY P CLACKSON
16 Feb 17
4
ALEXANDER J DENNER
16 Feb 17
4
Daniel M Bollag
16 Feb 17
4
Elona Esq. Kogan
16 Feb 17
4
NORBERT G RIEDEL
16 Feb 17
4
Jules Haimovitz
16 Feb 17
4
Anna Protopapas
16 Feb 17
4
Hugh M Cole
16 Feb 17
4
Sarah J. Schlesinger
16 Feb 17
SC 13G
Ariad Pharmaceuticals Inc
14 Feb 17
SC 13G/A
Ariad Pharmaceuticals Inc
10 Feb 17
SC 13G
Ariad Pharmaceuticals Inc
9 Feb 17
SC 13G/A
Ariad Pharmaceuticals Inc
9 Feb 17
4
Jayne M. Gansler
7 Feb 17
4
Hugh M Cole
7 Feb 17
4
Manmeet Singh Soni
7 Feb 17
4
TIMOTHY P CLACKSON
7 Feb 17
4
Daniel M Bollag
7 Feb 17
4
Jennifer Lyn Herron
7 Feb 17
4
Elona Esq. Kogan
7 Feb 17
4
ALEXANDER J DENNER
2 Feb 17
4
TIMOTHY P CLACKSON
2 Feb 17
4
Daniel M Bollag
2 Feb 17
4
George Bickerstaff
1 Feb 17
4
Jules Haimovitz
1 Feb 17
4
Anna Protopapas
1 Feb 17
4
NORBERT G RIEDEL
1 Feb 17
4
Sarah J. Schlesinger
1 Feb 17
SC 13G/A
Ariad Pharmaceuticals Inc
19 Jan 17
SC 13D
Ariad Pharmaceuticals Inc
18 Jan 17
4
Paris Panayiotopoulos
17 Jan 17